Valuation: Strides Pharma Science Limited

Market Cap 106B 1.11B 972M 919M 834M 1.57B 1.58B 11.01B 4.25B 54.15B 4.15B 4.06B 174B P/E 2027 *
16.9x
P/E 2028 * 12.1x
Enterprise Value 106B 1.11B 972M 919M 834M 1.57B 1.58B 11.01B 4.25B 54.15B 4.15B 4.06B 174B EV / Sales 2027 *
1.82x
EV / Sales 2028 * 1.54x
Free-Float
68.12%
Yield 2027 *
0.26%
Yield 2028 * 0.26%
1 day-2.83%
1 week-5.61%
Current month+12.33%
1 month+17.13%
3 months+6.39%
6 months+22.45%
Current year+27.88%
1 week 1,148.2
Extreme 1148.2
1,246.7
1 month 1,006.9
Extreme 1006.9
1,260.9
Current year 768.65
Extreme 768.65
1,260.9
1 year 768.65
Extreme 768.65
1,260.9
3 years 467
Extreme 467
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 01/06/2024
Director of Finance/CFO 42 01/06/2024
Chief Tech/Sci/R&D Officer - 21/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 18/05/2017
Director/Board Member 82 18/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.83%-5.61%+41.19%+123.18% 1.14B
-0.77%+0.04%+15.84%+61.24% 46.37B
+1.99%+2.81%+46.45%+112.71% 37.26B
+0.92%+4.74%+24.62%+100.78% 12.53B
-1.14%-0.77%-7.72%+17.21% 11.8B
+0.19%+0.19%+17.87%+140.09% 8.97B
-0.82%-2.35%+38.91%-18.31% 7.29B
-0.64%-3.35%+26.92%+37.17% 7.09B
-2.28%-4.97%+17.95%+199.55% 7.01B
-1.19%-1.78%-50.77%+1.98% 4.99B
Average -0.61%-0.53%+17.13%+77.56% 14.44B
Weighted average by Cap. +0.14%+0.39%+22.41%+79.20%

Financials

2027 *2028 *
Net sales 58.23B 607M 534M 505M 458M 859M 864M 6.04B 2.33B 29.71B 2.28B 2.23B 95.48B 69.12B 720M 633M 599M 543M 1.02B 1.03B 7.17B 2.77B 35.27B 2.7B 2.64B 113B
Net income 6.28B 65.39M 57.51M 54.39M 49.33M 92.64M 93.18M 651M 251M 3.2B 246M 240M 10.29B 8.8B 91.65M 80.61M 76.23M 69.14M 130M 131M 913M 352M 4.49B 344M 337M 14.43B
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
28/09/26 INR 1,151.40 -2.83% 115,834
25/09/26 INR 1,184.90 -1.49% 143,012
24/09/26 INR 1,202.80 -1.68% 126,615
23/09/26 INR 1,223.30 +0.48% 153,250
22/09/26 INR 1,217.40 -1.43% 285,056
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,151.40INR
Average target price
1,338.67INR
Spread / Average Target
+16.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAR Stock